Doug Roeder - Profile and Investment Details

Investor Profile

Doug Roeder is a Venture Capital, Private Equity Firm based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies, Phenomix, Astute Medical, Calithera Biosciences, PTC Therapeutics, TriVascular, PolyRemedy, Sotera Wireless, Anulex Technologies, Acclarent, Barosense, Pivot MedicalELENZA, PhotoThera, Sequent Medical, Evalve, LeddarTech, Senseonics, Incorporated, Relypsa, Aragon Surgical, Arbor Surgical Technologies, Syndicate, Cameron Health, PixelOptics, AEGEA Medical, Proteolix, EBR Systems, Primaeva Medical, Labcyte, Senseonics, NeurAxon, Breathe Technologies, Cardeas Pharma, Revance Therapeutics, VytronUS, NovaSys, ForSight Labs, Reliant Technologies, Tandem Diabetes Care, Vibrynt, Paracor Medical, NeuroVista, NOVASYS MEDICAL, Covalent, ForSight VISION5, Alder Biopharmaceuticals, SynergEyes, Ivantis, Proacta, OncoMed Pharmaceuticals, . Over time, Doug Roeder has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Doug Roeder is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Data Integration, Wearables, Autonomous Vehicles, Databases, Cryptocurrency, Automotive, Information Technology (IT), Software, Manufacturing, Biotechnology, Data Visualization, FinTech, Hardware, Health Diagnostics, Developer Tools, Medical, Sensors may find it worthwhile to explore potential connections with Doug Roeder, as their portfolio suggests a familiarity and interest in this area.

Understanding Doug Roeder’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.